Skip to content

Tongli Pharmaceuticals (USA), Inc.

company.status.inactive

CIK 1052284fmd_1YKTZRJH8BH39RQ27186XMV3RTManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2013, 15 periods

Latest annual · FY2013

Millions
Gross profit
6
Operating income
2
Net income
1
Free cash flow
6

Latest quarter · Q4 FY2013

Millions
Gross profit
0
Operating income
(0)
Net income
(0)
Open Financials

Tongli Pharmaceuticals (USA), Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Gross profit$5.6 million$5.8 million-3.1%10-K 2013-06-28 · proof
Operating income$2.2 million$3.3 million-32.1%10-K 2013-06-28 · proof
Net income$1.5 million$2.2 million-30.6%10-K 2013-06-28 · proof
Cash from operating activities$6 million-$285,02510-K 2013-06-28 · proof
Free cash flow$6 million-$285,89610-K 2013-06-28 · proof
Total assets$21.6 million$21.6 million-0.2%10-Q 2014-02-14 · proof
Total liabilities$859,334$1.2 million-26.9%10-Q 2014-02-14 · proof
Cash and cash equivalents$39,704$96,725-59%10-Q 2014-02-14 · proof
What was Tongli Pharmaceuticals (USA), Inc.'s gross profit in fiscal 2013?
Tongli Pharmaceuticals (USA), Inc. reported gross profit of $5.6 million for fiscal 2013 (the year ended Mar 31, 2013), against $5.8 million the year before (-3.1%). Source: the 10-K filed with the SEC on Jun 28, 2013. SEC
What was Tongli Pharmaceuticals (USA), Inc.'s operating income in fiscal 2013?
Tongli Pharmaceuticals (USA), Inc. reported operating income of $2.2 million for fiscal 2013 (the year ended Mar 31, 2013), against $3.3 million the year before (-32.1%). Source: the 10-K filed with the SEC on Jun 28, 2013. SEC
What was Tongli Pharmaceuticals (USA), Inc.'s net income in fiscal 2013?
Tongli Pharmaceuticals (USA), Inc. reported net income of $1.5 million for fiscal 2013 (the year ended Mar 31, 2013), against $2.2 million the year before (-30.6%). Source: the 10-K filed with the SEC on Jun 28, 2013. SEC
What was Tongli Pharmaceuticals (USA), Inc.'s cash from operating activities in fiscal 2013?
Tongli Pharmaceuticals (USA), Inc. reported cash from operating activities of $6 million for fiscal 2013 (the year ended Mar 31, 2013), against -$285,025 the year before. Source: the 10-K filed with the SEC on Jun 28, 2013. SEC
What was Tongli Pharmaceuticals (USA), Inc.'s free cash flow in fiscal 2013?
Tongli Pharmaceuticals (USA), Inc. reported free cash flow of $6 million for fiscal 2013 (the year ended Mar 31, 2013), against -$285,896 the year before. Source: the 10-K filed with the SEC on Jun 28, 2013. SEC
What are Tongli Pharmaceuticals (USA), Inc.'s total assets?
As of Dec 31, 2013, Tongli Pharmaceuticals (USA), Inc. reported total assets of $21.6 million, against $21.6 million a year earlier (-0.2%). Source: the 10-Q filed with the SEC on Feb 14, 2014. SEC
What are Tongli Pharmaceuticals (USA), Inc.'s total liabilities?
As of Dec 31, 2013, Tongli Pharmaceuticals (USA), Inc. reported total liabilities of $859,334, against $1.2 million a year earlier (-26.9%). Source: the 10-Q filed with the SEC on Feb 14, 2014. SEC
What are Tongli Pharmaceuticals (USA), Inc.'s cash and cash equivalents?
As of Dec 31, 2013, Tongli Pharmaceuticals (USA), Inc. reported cash and cash equivalents of $39,704, against $96,725 a year earlier (-59%). Source: the 10-Q filed with the SEC on Feb 14, 2014. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1052284&period_type=annual&limit=5"

Information only, not investment advice.